Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP

Last updated on 2024-03-11 History
Report ID 189373
Drug Identification Number 02433443
Brand name JAMP-NYSTATIN ORAL SUSPENSION USP
Common or Proper name Nystatin Oral Suspension USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) NYSTATIN
Strength(s) 100000UNIT
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 500
ATC code A07AA
ATC description INTESTINALANTIINFECTIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-04-12
Estimated end date 2024-04-15
Actual end date
Shortage status Actual shortage
Updated date 2024-03-11
Company comments Allocations
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2024-03-11 French Compare
v20 2024-03-11 English Compare
v19 2024-03-04 French Compare
v18 2024-03-04 English Compare
v17 2023-12-18 French Compare
v16 2023-12-18 English Compare
v15 2023-09-26 French Compare
v14 2023-09-26 English Compare
v13 2023-09-11 French Compare
v12 2023-09-11 English Compare
v11 2023-08-25 French Compare
v10 2023-08-25 English Compare
v9 2023-08-08 French Compare
v8 2023-08-08 English Compare
v7 2023-08-03 French Compare
v6 2023-08-03 English Compare
v5 2023-05-10 French Compare
v4 2023-05-10 English Compare
v3 2023-04-13 English Compare
v2 2023-04-12 French Compare

Showing 1 to 20 of 21